Shuttle Pharmaceuticals Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SHPH research report →
Price Chart
About the company
Shuttle Pharmaceuticals Holdings, Inc. , a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development.
- CEO
- Christopher Robert Cooper
- IPO
- 2022
- Employees
- 2
- HQ
- Gaithersburg, MD, US
Get TickerSpark's AI analysis on SHPH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $16.63M
- P/E
- -0.11
- PEG
- -0.01
- P/S
- 0.00
- P/B
- 0.18
- EV/EBITDA
- -1.77
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -156.78%
- ROIC
- -57.80%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-11,916,824
- Net Income
- $-11,721,669-28.2%
- EPS
- $-71.60+99.2%
- OCF Growth
- -29.4%
- FCF Growth
- -29.4%
- 52W High
- $44.40
- 52W Low
- $2.58
- 50D MA
- $4.53
- 200D MA
- $5.93
- Beta
- 1.14
- RSI (14)
- 32
- Avg Volume
- 41.80K
No earnings-call transcripts are available for SHPH yet.
- Free Float
- 99.8%
- Shares Outstanding
- 4.76M
- Float Shares
- 4.76M
of shares held by institutions
7 13F filers
Buy/sell ratio 0.80. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Ayrton Capital LLC | 220.43K | ▼ 30.49K |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 13, 26 | HRT FINANCIAL LP | sell | 1,033 |
| Jul 14, 26 | HRT FINANCIAL LP | sell | 82,116 |
| Jul 10, 26 | HRT FINANCIAL LP | buy | 731 |
| Jul 9, 26 | HRT FINANCIAL LP | buy | 8,266 |
| Jul 9, 26 | HRT FINANCIAL LP | other | 0 |
| Jul 7, 26 | HRT FINANCIAL LP | sell | 10,580 |
| Jul 8, 26 | HRT FINANCIAL LP | sell | 18,531 |
| Jul 2, 26 | HRT FINANCIAL LP | buy | 7,851 |
| Jul 6, 26 | HRT FINANCIAL LP | sell | 9,022 |
| Jul 1, 26 | HRT FINANCIAL LP | buy | 3,959 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our SHPH coverage
Recent articles, reports, and earnings notes.
No research on SHPH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SHPH report →Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Short Interest Update
defenseworld.net · Oct 2
Shuttle Pharmaceuticals Holdings, Inc. Announces Receipt of NASDAQ Noncompliance Letter
newsfilecorp.com · Aug 28
Daiichi Sankyo (OTCMKTS:DSNKY) & Shuttle Pharmaceuticals (NASDAQ:SHPH) Head to Head Contrast
defenseworld.net · Jul 22
United Dogecoin Purchases Dogecoin Miners and Secures Renewable Energy Data Centre Site
newsfilecorp.com · Jun 26
United Dogecoin Advances Data Centre and Power Infrastructure Strategy to Support DOGE Mining and AI Hosting
newsfilecorp.com · Jun 25
Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 11, 2026, at 12:01 a.m., Eastern Time
newsfilecorp.com · Jun 9
Shuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining Rigs
newsfilecorp.com · May 14
E.F. Hutton & Co. Serves as Exclusive M&A Advisor and Placement Agent on Completed Shuttle Pharmaceuticals–United Dogecoin Merger to Create the Largest Public Dogecoin Miner
globenewswire.com · May 7
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.